Page last updated: 2024-12-06

4-amino-n-ethyl-n-(beta-hydroxy-ethyl)-m-toluidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-amino-N-ethyl-N-(beta-hydroxy-ethyl)-m-toluidine: causes allergic contact dermatitis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75383
SCHEMBL ID793452
MeSH IDM0364394

Synonyms (21)

Synonym
AKOS005431278
OPREA1_239653
2359-51-5
2-(4-amino-n-ethyl-m-toluidino)ethanol
brn 2721803
einecs 219-104-4
cd 4 color developer
4-amino-n-ethyl-n-(beta-hydroxy-ethyl)-m-toluidine
m-toluidine, 4-amino-n-ethyl-n-(beta-hydroxyethyl)-
2-[(4-amino-3-methylphenyl)(ethyl)amino]ethanol
STK396653
2-(4-amino-n-ethyl-3-methylanilino)ethanol
BBL003986
2-[4-amino(ethyl)-3-methylanilino]-1-ethanol
SCHEMBL793452
n-hydroxyethyl-n-ethyl-3-methyl-p-phenylenediamine
cd-4
ethanol, 2-[(4-amino-3-methylphenyl)ethylamino]-
2-((4-amino-3-methylphenyl)(ethyl)amino)ethanol
CAA35951
DTXSID50865242
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's5 (50.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.88 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (45.45%)4.05%
Observational0 (0.00%)0.25%
Other6 (54.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]